ASM ESCMID 2018 1230x300

Important Dates

Abstract Submission Closes: August 1, 2018

Meeting Location 

Intercontinental Lisbon
R. Castilho 149, 1099-024
Lisbon, Portugal

Program Committee

Murat Akova, Ankara, Turkey
Maiken Arendrup, Copenhagen, Denmark
Sujata Bhavnani, Schenectady, NY
Marco Cavaleri, London, United Kingdom
Herman Goossens, Edegem, Belgium
David Hooper, Boston, MA
William Hope, Liverpool, United Kingdom
Sumathi Nambiar, Washington DC
John Rex, Wellesley, MA
Jesús Rodríguez Baño, Seville, Spain
Keith Rodvold, Chicago, IL
Michael Sharland, London, United Kingdom
Judith Steenbergen, Boston, MA

Follow @ASMicrobiology on Twitter and use #ASMESCMID for the latest conference updates. 


2018 ESCMID/ASM Conference on Drug Development

For information on the 2018 ASM/ESCMID Conference, please visit:

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR. 

Access 2017 ASM/ESCMID Conference materials 

 Spread the word. Download the 2018 ESCMID/ASM Conference flyer